Patent Assignment
Reel/Frame 071152/0822
Change of Name
Recorded: 2025-05-19
Pages: 5
Assignor
GW RESEARCH LIMITED
Executed: 2023-11-20
Assignee
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
BUILDING 730 KENT SCIENCE PARK, SITTINGBOURNE, ME9 8AG, UNITED KINGDOM
Covered Property
(1)
Use of Cannabidiol in the Treatment of Seizures Associated with Rare Epilepsy Syndromes Related to Genetic Abnormalities
Application:
18/006,121 →
Publication:
US 2023/0285426
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 14, 2023
From: CHECKETTS, DANIEL ADAM; CRAIG, KEVIN JAMES
To: GW RESEARCH LIMITED
Reel/Frame 064583/0069 →
Corrective Assignment to Correct the Country Is "Untied Kingdom" Previously Recorded at Reel: 064583 Frame: 0069. Assignor(S) Hereby Confirms the Assignment.
Aug 25, 2023
From: CHECKETTS, DANIEL ADAM; CRAIG, KEVIN JAMES
To: GW RESEARCH LIMITED
Reel/Frame 064719/0529 →
Security Agreement
Jul 26, 2024
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; GW PHARMA LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 068173/0155 →